MedTrace Logo

Implementation of the NEDS EyeCTester App

NCT04607369 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-04-13

No results posted yet for this study

Summary

Group 4a and 4b was an FDA trial that showed that patients who have an Amsler grid abnormality on paper, have a similar abnormality on the app.

Group 7a and 7b was an FDA trial that showed that normal patients do not have false positives on the Amsler app as well as on the Amsler paper version. Further Vision on the app is slightly better than vision on the standard Sloan near card using a formula (vision is 7/10th of a line better on the app).

Conditions

  • Optic Nerve Disease
  • Macular Disease
  • Visual Pathway Disorder

Interventions

DEVICE

EyeCTester

Smartphone app that allows vision testing

Sponsors & Collaborators

  • Neuro-ophthalmology of Texas PLLC

    collaborator UNKNOWN

  • Neuro-Eye Diagnostic Systems, LLC

    lead INDUSTRY

Principal Investigators

  • Rosa A Tang, MD · Neuro-ophthalmology of Texas

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-09
Primary Completion
2027-12-31
Completion
2028-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04607369 on ClinicalTrials.gov